Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

GLAND PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹163 Cr₹170 Cr₹84 Cr₹88 Cr₹74 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of GLAND PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of GLAND PHARMA is ₹163 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹163 Cr
Mar2024₹170 Cr
Mar2023₹84 Cr
Mar2022₹88 Cr
Mar2021₹74 Cr

How is Deferred Tax Assets / Liabilities of GLAND PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹163 Cr
-4.09
Mar2024 ₹170 Cr
101.52
Mar2023 ₹84 Cr
-4.05
Mar2022 ₹88 Cr
18.79
Mar2021 ₹74 Cr -

Compare Deferred Tax Assets / Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹28,125.6 Cr 2.3% -8.6% 3.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹414,713.0 Cr -1.4% -3.2% -0.5% Stock Analytics
DIVIS LABORATORIES ₹156,811.0 Cr -1.9% -8.7% 1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹139,052.0 Cr -3.5% -6.6% 30.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,927.0 Cr -4% -8.3% 6.3% Stock Analytics
CIPLA ₹96,602.7 Cr -1.9% -11.9% -19% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

2.3%

-8.6%

3.8%

SENSEX

0.6%

-11.1%

-6.2%


You may also like the below Video Courses